Annexon ANNX
NASDAQ ANNX
$4.87 +0.03 (+0.62%)
As of: Sep 4, 2026 · 3:59 PM EDT

Annexon (ANNX) Retained Earnings (2019 - 2026)

Annexon (ANNX) posted quarterly Retained Earnings of $1.2 billion for Q1 2026, up 1281400.0% year-over-year from N/an in Q1 2025, and up 4020731.03% quarter-over-quarter from -$29000.0 in Q4 2025.

Analysis

Annexon (ANNX) Retained Earnings (2019 - 2026) Analysis & Trends

Annexon's Retained Earnings history runs 8 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

  • In Q1 2026, Retained Earnings rose 1281400.0% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $1.2 billion (up 1281400.0% YoY), while the FY2025 annual figure was -$29000.0, up 100.0% from the prior year.
  • Retained Earnings for Q1 2026 stood at $1.2 billion, up from -$29000.0 in the prior quarter.
  • The five-year high for Retained Earnings was $1.2 billion in Q1 2026, with the low at -$869.1 million in Q3 2025.
  • The 5-year median for Retained Earnings is -$368.8 million (2022), against an average of -$213.9 million.
  • The sharpest annual moves came in 2025 and 2026: Retained Earnings plunged 914731.46% in 2025, then jumped 1281400.0% in 2026.
  • Annexon's Retained Earnings stood at -$438.3 million in 2022, then slumped by 30.63% to -$572.5 million in 2023, then decreased by 24.14% to -$710.7 million in 2024, then jumped by 100.0% to -$29000.0 in 2025, then jumped by 4020731.03% to $1.2 billion in 2026.
  • Business Quant data shows ANNX's Retained Earnings at $1.2 billion in Q1 2026, -$29000.0 in Q4 2025, and -$869.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Annexon 982.93 Mn 982.93 Mn - 1.20 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Bn
Mar 31, 2026 1.17 Bn
Dec 31, 2025 1.13 Bn
Sep 30, 2025 1.03 Bn
Jun 30, 2025 1.01 Bn
Mar 31, 2025 1.01 Bn
Dec 31, 2024 1.00 Bn
Sep 30, 2024 993.49 Mn
Jun 30, 2024 988.35 Mn
Mar 31, 2024 860.09 Mn
Dec 31, 2023 823.03 Mn
Sep 30, 2023 701.52 Mn
Jun 30, 2023 696.97 Mn
Mar 31, 2023 691.96 Mn
Dec 31, 2022 669.78 Mn
Sep 30, 2022 664.84 Mn
Jun 30, 2022 537.27 Mn
Mar 31, 2022 532.64 Mn
Dec 31, 2021 528.37 Mn
Sep 30, 2021 523.46 Mn